Red-cell sodium-lithium countertransport and fractional excretion of lithium in normal and hypertensive humans.
To examine the relations between erythrocyte sodium-lithium countertransport and renal proximal tubular sodium handling, we measured countertransport, and then subjected 30 normal and 32 hypertensive subjects, both white and black, to provocative maneuvers of volume expansion and contraction. The fractional excretions of sodium and lithium were measured simultaneously. In agreement with previous studies, we found that countertransport in erythrocytes was elevated in hypertensive patients compared with normal subjects. We also observed that whites have a higher level of countertransport than blacks. In the basal state, we found that fractional sodium excretion of hypertensive patients was no different than in normal subjects, whereas the fractional lithium excretion of hypertensive persons was increased compared with normotensive values. Volume expansion with 2 1 0.9% saline administered intravenously during a 4-hour period provoked an exaggerated natriuresis and a greater increase in fractional lithium clearance in hypertensive patients compared with the control group. With volume expansion and contraction, fractional lithium clearance and countertransport were directly correlated. Our data suggest that hypertensive persons do not have increased proximal tubular sodium reabsorption compared with normal subjects. Further, the exaggerated natriuresis of hypertension is, in part, the result of increased distal solute delivery. The fact that our hypertensive patients were older may partially explain the discrepancies between this report and previous observations.
Weinberger
M H
MH
Department of Medicine, Indiana University School of Medicine, Indianapolis.
Smith
J B
JB
Fineberg
N S
NS
Luft
F C
FC
D001692:Biological Transport; D044383:Black People; D003404:Creatinine / Q000032:analysis; D004912:Erythrocytes / Q000378:metabolism*; D005260:Female; D005665:Furosemide / Q000008:administration & dosage; D006801:Humans; D006973:Hypertension / Q000378:metabolism*; D007687:Kidney Tubules, Proximal / Q000187:drug effects / Q000378:metabolism; D008094:Lithium / Q000008:administration & dosage / Q000032:analysis / Q000493:pharmacokinetics*; D016651:Lithium Carbonate; D008297:Male; D009318:Natriuresis / Q000187:drug effects; D012964:Sodium / Q000097:blood* / Q000652:urine; D012965:Sodium Chloride / Q000008:administration & dosage; D044465:White People
D016651:Lithium Carbonate; D012965:Sodium Chloride; D005665:Furosemide; D008094:Lithium; D012964:Sodium; D003404:Creatinine